Stay updated with breaking news from Michaelj haller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hybrid closed-loop may be more cost-effective than immune therapies for type 1 diabetes healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Q&A: Increased awareness may boost uptake of inhaled insulin healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients. ....
MannKind Announces First Patient Enrolled in INHALE-1 Study of Afrezza® in Pediatric Population streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.